Insulin resistance (hyperglycemia)Increased insulin demandsFluid retention (usually self-limiting)Hypercalcemia (uncommon with short-term use)Increase in metabolic rateMust be given parenterally. This evidence concerns the gene INS and hypercalcemia disease.